Skip to main content
OpenTrials

Clinical trial condition

Retinal Diseases

Explore clinical trials studying Retinal Diseases. Study availability and eligibility vary by location and protocol.

2,349 public trials 291 recruiting studies
Refine in advanced search Browse all conditions

Retinal Diseases trial results

Completed

A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

NCT04740671

Conditions
Age Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Associated Retina Consultants-Gilbert Gilbert, Arizona, United States
  • Associated Retina Consultants-Phoenix Phoenix, Arizona, United States
  • Retina Consultants of Orange County Fullerton, California, United States
  • Global Research Management Glendale, California, United States
View all 126 locations
View Trial Details
Completed

The Perceptual Experience of Argus II Users

NCT05285618

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • University of California, Santa Barbara Santa Barbara, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan, Ann Arbor Ann Arbor, Michigan, United States
View Trial Details
Completed

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion

NCT05532735

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +5 more
Locations
  • Eye Associates of Northeast Louisiana West Monroe, Louisiana, United States
  • Cumberland Valley Retina Consultants Hagerstown, Maryland, United States
  • Tulsa Retina Consultants Tulsa, Oklahoma, United States
  • Retina Consultants of Texas Bellaire, Texas, United States
View Trial Details
Completed

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

NCT04047472

Conditions
Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +9 more
Locations
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Shantou, Guangdong, China
View all 30 locations
View Trial Details

Related conditions